98H Stock Overview
A medical device company, develops, markets, and sells products for sports medicine. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
PolarCool AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.0002 |
| 52 Week High | SEK 0.018 |
| 52 Week Low | SEK 0.0002 |
| Beta | 0.89 |
| 11 Month Change | 0% |
| 3 Month Change | -92.86% |
| 1 Year Change | -95.24% |
| 33 Year Change | -99.94% |
| 5 Year Change | n/a |
| Change since IPO | -99.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| 98H | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -92.9% | -2.5% | -1.3% |
| 1Y | -95.2% | -8.4% | 7.4% |
Return vs Industry: 98H underperformed the German Medical Equipment industry which returned -8.4% over the past year.
Return vs Market: 98H underperformed the German Market which returned 7.4% over the past year.
Price Volatility
| 98H volatility | |
|---|---|
| 98H Average Weekly Movement | 2,715.0% |
| Medical Equipment Industry Average Movement | 5.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 98H's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 98H's weekly volatility has increased from 2037% to 2715% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 3 | Erik Andersson | www.polarcool.se |
PolarCool AB (publ), a medical device company, develops, markets, and sells products for sports medicine. The company offers PolarCap System, a portable cooling device for the treatment of concussive and sub-concussive brain injury. It serves teams, organizations, and athletes.
PolarCool AB (publ) Fundamentals Summary
| 98H fundamental statistics | |
|---|---|
| Market cap | €3.34m |
| Earnings (TTM) | -€914.87k |
| Revenue (TTM) | €139.66k |
23.9x
P/S Ratio-3.7x
P/E RatioIs 98H overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 98H income statement (TTM) | |
|---|---|
| Revenue | SEK 1.61m |
| Cost of Revenue | SEK 97.00k |
| Gross Profit | SEK 1.51m |
| Other Expenses | SEK 12.03m |
| Earnings | -SEK 10.52m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 29, 2024
| Earnings per share (EPS) | -0.0084 |
| Gross Margin | 93.96% |
| Net Profit Margin | -655.08% |
| Debt/Equity Ratio | 0% |
How did 98H perform over the long term?
See historical performance and comparison